Want to see JP:2385 full AI Analyst Report?

Soiken Holdings Inc. (2385) Price & Analysis

0 Followers

2385 Stock Chart & Stats

¥236.00

-¥3.00(-2.38%)

At close: Jan 08 4:00 PM EST

¥236.00

-¥3.00(-2.38%)

Day’s Range― - ―

52-Week Range¥156.00 - ¥325.00

Previous CloseN/A

Volume39.40K

Average Volume (3M)187.76K

Market Cap

¥5.39B

Enterprise Value¥986.41M

Total Cash (Recent Filing)¥5.26B

Total Debt (Recent Filing)¥0.00

Price to Earnings (P/E)29.3

Beta0.93

Next Earnings

Aug 19, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield2.08%

Share Statistics

EPS (TTM)-8.04

Shares Outstanding26,158,200

10 Day Avg. Volume461,280

30 Day Avg. Volume187,763

Financial Highlights & Ratios

PEG Ratio0.31

Price to Book (P/B)0.73

Price to Sales (P/S)0.91

P/FCF Ratio8.43

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Debt-free Balance SheetA zero-debt capital structure provides durable financial flexibility: the company can fund operations, R&D, or partnerships without interest burden, withstand revenue shocks longer, and avoid leverage-driven insolvency risks, supporting strategic optionality over months.

FY2025 Cash-flow RecoveryRebounding operating and free cash flow in FY2025 materially improves internal funding capacity. Sustained positive cash generation reduces reliance on external financing, funds ongoing programs, and rebuilds cash reserves—strengthening the company's runway and strategic execution over the medium term.

Stable Gross Margins & Narrowing LossesStable ~48%–50% gross margins indicate durable product-level economics, suggesting unit profitability exists. The narrowing of losses in FY2025 signals improving operating leverage and cost control; if top-line stabilizes, these structural margins support a credible path back to sustained profitability.

Bears Say

Multi-year Revenue ContractionPersistent top-line decline erodes scale and weakens the firm's ability to absorb fixed costs, harming long-term margin recovery. Multi-year revenue contraction undermines market position and raises execution risk: reversing the trend is necessary for durable profitability and cash stability.

Recent Unprofitable Operating PerformanceConsecutive annual losses reflect structural profitability issues; negative net margins and recent negative returns on equity mean internal capital generation is insufficient. Prolonged unprofitability can deplete equity cushions and force restructuring or equity raises, impairing strategic choices.

Volatile Cash Generation HistoryWhile FY2025 improved, the prior multi-year cash burn demonstrates inconsistent cash generation. This volatility raises financing and execution risk: if cash flow reverts, the company may face funding shortfalls despite zero debt, complicating long-term program support and planning.

2385 FAQ

What was Soiken Holdings Inc.’s price range in the past 12 months?

Soiken Holdings Inc. lowest stock price was ¥156.00 and its highest was ¥325.00 in the past 12 months.

What is Soiken Holdings Inc.’s market cap?

Soiken Holdings Inc.’s market cap is ¥5.39B.

When is Soiken Holdings Inc.’s upcoming earnings report date?

Soiken Holdings Inc.’s upcoming earnings report date is Aug 19, 2026 which is in 47 days.

How were Soiken Holdings Inc.’s earnings last quarter?

Soiken Holdings Inc. released its earnings results on May 13, 2026. The company reported ¥3.16 earnings per share for the quarter, beating the consensus estimate of N/A by ¥3.16.

Is Soiken Holdings Inc. overvalued?

According to Wall Street analysts Soiken Holdings Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Soiken Holdings Inc. pay dividends?

Soiken Holdings Inc. pays a Annually dividend of ¥10 which represents an annual dividend yield of 2.08%. See more information on Soiken Holdings Inc. dividends here

What is Soiken Holdings Inc.’s EPS estimate?

Soiken Holdings Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Soiken Holdings Inc. have?

Soiken Holdings Inc. has 26,158,200 shares outstanding.

What happened to Soiken Holdings Inc.’s price movement after its last earnings report?

Soiken Holdings Inc. reported an EPS of ¥3.16 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.394%.

Which hedge fund is a major shareholder of Soiken Holdings Inc.?

Currently, no hedge funds are holding shares in JP:2385

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Soiken Holdings Inc.

Founded in 1994 and headquartered in Toyonaka, Japan, Soiken Holdings Inc. primarily focuses on the advancement of biomarkers. The company’s operations span a diverse range of health and wellness sectors. It is actively involved in the creation and commercialization of cosmetics and nutritional supplements, alongside the licensing and continued development of biomarker technologies. Soiken also conducts market research and post-market surveillance specifically for dietary supplements. A key area of its work includes the research, development, and sale of functional materials like lactoferrin, as well as pharmaceuticals derived from ascochlorin. Furthermore, Soiken applies its biomarker expertise to perform clinical evaluations for food products. The company extends its services to provide vital support for physician-initiated pharmaceutical clinical research, comprehensive health screenings, and personalized health guidance. It also partners with health insurance societies to offer contracted health guidance, facilitate specialized health check-ups for dependents of the insured, and implement programs designed for diabetes prevention.